Real-World Evaluation of Dupilumab in the Long-Term Management of Eosinophilic Chronic Rhinosinusitis with Nasal Polyps: A Focus on IL-4 and IL-13 Receptor Blockade by Nicola Lombardo, Aurelio D’Ecclesia, Emanuela Chiarella, Corrado Pelaia, Debbie Riccelli, Annamaria Ruzza, Nadia Lobello, Giovanna Lucia Piazzetta

Subjects: Get full text

Roads to remission: evolving treatment concepts in type 2 inflammatory diseases by Marek Lommatzsch, Katharina Blumchen, Lisa A. Beck, Jean Bousquet, Guy G. Brusselle, Wytske J. Fokkens, Eckard Hamelmann, Susanne Lau, Hagen Ott, Oliver Pfaar, Hugh A. Sampson, Josef S. Smolen, Christian Taube, Ingo H. Tarner, Martin Wagenmann, Thomas Werfel, Margitta Worm, Harald Renz

Subjects: Get full text

Biological treatment options for eosinophilic asthma, with consideration of markers of eosinophilic inflammation as predictors of treatment efficacy by Aleksandra Niemiec, Olga Branicka, Barbara Rymarczyk, Radosław Gawlik

Subjects: Get full text

The role of NLRP3 inflammasome in type 2 inflammation related diseases by Shenming Xu, Dan Wang, Lina Tan, Jianyun Lu

Subjects: Get full text

Biological targeted therapy for type 2 inflammation bronchial asthma by ZHANG Mingqiang, MU Xiangdong

Subjects: “…bronchial asthma|type 2 inflammation|biological targeted therapy…”
Get full text

European biologic training course for type 2 inflammation by EUFOREA in 2024: key facts and lessons learned by D. M. Conti, D. M. Conti, D. M. Conti, V. Backer, W. Fokkens, P. Gevaert, A. Peters, G. K. Scadding, G. K. Scadding, I. Pavord, S. Lau, M. Wechsler, M. Wechsler, X. Bertels, X. Bertels, G. Liva, M. Doulaptsi, E. Prokopakis, P. W. Hellings, P. W. Hellings, P. W. Hellings

Subjects: Get full text

Beneficial effects of ultrafine bubble shower on a mouse model of atopic dermatitis by Ayaki Matsumoto, Ayaki Matsumoto, Hisayoshi Imanishi, Hisayoshi Imanishi, Mika Yamanaka-Takaichi, Mika Yamanaka-Takaichi, Masateru Hirae, Daisuke Tsuruta, Daisuke Tsuruta, Kozo Nakai, Kozo Nakai, Kozo Nakai

Subjects: Get full text

Canadian Rhinology Working Group consensus statement: biologic therapies for chronic rhinosinusitis by Andrew Thamboo, S. Kilty, I. Witterick, Y. Chan, C. J. Chin, A. Janjua, A. Javer, J. Lee, E. Monterio, B. Rotenberg, J. Scott, K. Smith, D. D. Sommer, L. Sowerby, M. Tewfik, E. Wright, M. Desrosiers

Subjects: Get full text

IL-27 as a novel biomarker for pruritus in nodular prurigo and bullous pemphigoid by Yifei Wang, Xin Zhang, Yun Te Teng, Chen Shen

Subjects: Get full text

Evaluation Checklist for the Multidisciplinary Approach to Patients with Asthma or Suspected Asthma in United Airway Disease by Almonacid C, Ausín P, Villacampa JM, Dávila I, Pinilla M, Dominguez-Ortega J

Subjects: Get full text

Gαi1/3 signaling mediates IL-5-induced eosinophil activation and type 2 inflammation in eosinophilic chronic rhinosinusitis by Huanxia Xie, Jiang Ji, Zhichen Liu, Ning Lu, Yuqian Wei, Aina Zhou, Jisheng Liu, Qingqing Jiao, Qingqing Jiao

Subjects: Get full text